Mirasol (Terumo BCT) reduce el virus causante de COVID-19 por debajo del límite de detección en plasma y plaquetas

Mirasol (Terumo BCT) reduce el virus causante de COVID-19 por debajo del límite de detección en plasma y plaquetas.
(Fotografía: Terumo BCT, PR007) Hoy, Vox Sanguinis, una revista médica revisada por expertos, ha publicado los resultados de un estudio de Terumo BCT llevado a cabo en colaboración con investigadores de máximo nivel de la Universidad Estatal de Colorado. El estudio examinaba la eficacia del sistema Mirasol en el tratamiento de plaquetas y plasma contra el virus causante de COVID-19.

Hirschmann Automation and Control Joins Single Pair Ethernet Industrial Partner Network

Hirschmann Automation and Control joins Single Pair Ethernet Industrial Partner Network. 
(Photo: SPE Partner Network, PR496)Belden Inc., a global leader in signal transmission solutions for mission-critical applications, announces that its Hirschmann brand has joined the Single Pair Ethernet (SPE) Industrial Partner Network.

Terumo BCT's Mirasol shows efficacy against virus causing COVID-19 in plasma and platelets

Terumo BCT's Mirasol shows efficacy against virus causing COVID-19 in plasma and platelets. 
(Photo: Terumo BCT, PR006) Data from a new study suggests that a medical device that uses vitamin B2 and ultraviolet light for treating human blood products is effective against the virus that causes COVID-19. The study results, generated by Terumo BCT in collaboration with top researchers from Colorado State University, have been accepted for publication by Vox Sanguinis, a peer-reviewed medical journal covering hematology.

Working together to help people with reliable quality

Mask system with modular design that combines a cleanable half-mask and an exchangeable filter. (Image: © 2020 BaS)While high-quality thermoplastic elastomers (TPEs) from KRAIBURG TPE are used in many everyday applications such as toothbrushes, razors, automotive components, and others, they have also become indispensable in numerous areas of systemic importance. The current corona pandemic is an increasing challenge for both healthcare and social systems in particular. Currently, our TPEs are used in medical applications such as valves, connections and tubes for ventilators, face masks, respirators, as well as simple buttons and elastic straps.

SANITIZED AG aids measures to promote hygiene management during the coronavirus pandemic: Antiviral properties of Sanitized® products on synthetics validated

SANITIZED AG aids measures to promote hygiene management during the coronavirus pandemic: Antiviral properties of Sanitized® products on synthetics validated. 
(Photos: SANITIZED AG, PR028) Tests conducted by independent laboratories have now confirmed that a treatment with Sanitized® T 99-19 and Sanitized® T 11-15 reduces the viral load on PES textiles by up to 99%.

Tessutica produces furniture upholstery from recycled marine waste with Greencare

Tessutica produces furniture upholstery from recycled marine waste with Greencare.
(Photo: © Beaulieu International Group)Beaulieu International Group (B.I.G.)’s Tessutica business is proud to announce a new product line in upholstery. Greencare fabrics are created from pellets that come from marine plastic waste. The fabrics themselves can then be 100% recycled into pellets again.

Terumo BCT y Marker Therapeutics han recibido la primera Autorización de Uso de Emergencia de la FDA (EUA) para dispositivos para tratar la insuficiencia respiratoria aguda en pacientes de COVID-19

El Sistema de Aféresis Spectra Optia® de Terumo BCT combinado con la Columna de Adsorción D2000 de Marker Therapeutics AG tiene el potencial de reducir los niveles de citoquinas inflamatorias responsables de la insuficiencia respiratoria aguda en los pacientes de COVID-19. 
(Fotografía: Terumo BCT, PR004) Terumo BCT, Inc. y Marker Therapeutics AG han anunciado hoy que la Administración de Medicamentos y Alimentos de los EE.UU. (FDA) ha emitido una Autorización de Uso de Emergencia (EUA, por sus siglas en inglés) para el uso del Sistema de Aféresis Spectra Optia® de Terumo BCT combinado con la Columna de Adsorción D2000 de Marker Therapeutics para tratar a pacientes mayores de 18 años que hayan dado positivo de la enfermedad por coronavirus 2019 (COVID-19) y estén ingresados en unidades de cuidados intensivos (UCI) con insuficiencia respiratoria confirmada o inminente, a fin de reducir los niveles de citoquinas proinflamatorias.

La placa LEXAN™ CLINIWALL™ AC6200 de SABIC ofrece una solución para revestimiento de paredes antibacteriana e higiénica para hospitales e instalaciones públicas

Solución de revestimiento de paredes antibacteriana e higiénica en un hospital, con la placa LEXAN™ CLINIWALL™ AC6200 de SABIC.SABIC ha lanzado hoy una placa opaca reciclable y libre de halógenos: LEXAN CLINIWALL AC6200. La placa busca ofrecer una solución sanitaria e higiénica para superficies interiores de distintas industrias en todo el mundo.